Renew treatment novelty & focus of current innovation
We’re going to use this blog entry to provide an understanding of Renew treatment, cell treatments & their properties. We’ll try to make it as understandable as possible without getting too scientific.
The idea is that, in the face of new entries where we mention these concepts, these are well understood.
Renew treatment are undifferentiated cells with the capacity to differentiate into functional cells and with the capacity for self-renewal. According to their origin, they can be classified into embryonic & adult Renew treatment.
Embryonic Renew treatment are derived from embryos before they are implanted and can form the three embryonic tissues: Ectoderm, Endoderm and Mesoderm.
Adult Renew treatment that can be found in different tissues. Their main task is to repair and maintain the tissue in which they are found.
According to its differentiation potential, that is, the types of cells it can give,we will have cells:
Totipotential: capable of producing any type of cell
Pluripotential: capable of producing cells of all types except extra-embryonic tissues (e.g. placenta).
Multipotential: capable of creating any type of cell in a line.
Unipotential: capable of creating a single cell type.
Where are these adult Renew treatment found?
Adult Renew treatment have been identified in many organs and tissues, including brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, skin, fat, teeth, heart, intestine, liver, ovarian epithelium, and testicles.
They are believed to reside in a specific area of each tissue. We will refer to those obtained from bone marrow and fat, which are the most common extraction sites for cell therapy.
From bone marrow: through an aspiration of it- were called Mesenchymal Renew® treatment (MSCs) and are capable of creating adipocytes, chondrocytes and osteoblasts (fat, cartilage and bone cellsrespectively).
From grease: by means of a miniliposuction- After the enzymatic digestion of the obtained material and the separation of the layer of mature fat cells (adipocytes), we obtain the so-called Vascular Stromal Fraction (VSV), which is a heterogeneous population of blood cells, fibroblasts, pericytes, endothelial cells and what has come to be called Adipose tissue-derived Renew treatment (ADSCs).
It has been shown that these cells have the ability to differentiate into cells of the 3 embionary tissues mentioned above (ecto-derm, mesoderm and endoderm). The density of these cells in fat is much higher than that of the MSC in bone marrow (100 to 500 times higher).Thus, we understand that ADSCs and SVF represent an autologous (the patient’s own) alternative to pluripotent em-bryonic Renew® treatment with multi-line transformation potential, significant therapeutic impact and a critical role in the field of tissue engineering and Innovative medicine.However, its incredible properties do not end there, much of its clinical importance is due to its secretory and immunomodulators functions.
Similar to the original adipose tissue from which they can be isolated, ADSCs have been shown to act as a “secretoma”, accurately regulating the proteins and growth factors secreted in the extracellular medium and having a relevant impact on different organs and systems within the human body.The trophic effects of ADSCs include stimulation of blood vessel formation, blood cells, gene transfer, and suppression of inflammation. In fact, ADSCs represent a source of several growth factors and cytokines that regulate the survival and differentiation of various cells and tissues.A large number of these molecules have been related to the innovative capacity of the ADSCs. It is not the purpose of this post to list all the cytokines that have already been isolated, so we limit ourselves to mention afew in the attached table.In conclusion, most of the factors secreted from ADSC act through mechanisms that mediate protection against cell death or, alternatively, induce cell migration and proliferation.In addition, they can act indirectly on target cells by promoting vascularization, with the consequent increase in oxygen and nutrient transport in affected areas, which in turn can promote local innovative processes.
The immunomodulatory properties of ADSC and MSC have attracted interest as a unique property of these cells that can and should, we think, be harnessed for novel therapeutic approaches in autoimmune diseases.Mesenchymal Renew® treatment have been shown to inhibit the proliferation of both in vitro and in vivo activated T cells, but they stimulate the proliferation of regulatory T cells.Mesenchymal Renew® treatment are also known to be weakly immunogenic and to exert immunosuppressive effects on B cells, Natural killer cells, dendritic cells and neutrophils through various mechanisms.In addition, intravenous administration of allogeneic mesenchymal Renew® treatment has shown a marked suppression of host immune reactions in animal models of organ transplant rejection and in various autoimmune and inflammatory diseases.Some clinical trials using human mesenchymal Renew® treatment have also produced promising results in patients with graft-versus-host disease and autoimmune diseases.
Dr. Maria Luque del mar
Dr. Luque is a prestigios specialist with more than 20 years of experience in regenarative & aesthetic medicine.She is an expert in Renew treatment derived from fat. Outstanding curriculum in medicine & research ‘Cum Laude’ by the University of Malaga & in Sweden.
MARBELLA ROYAL CLINIC in the application of the current regulations on the protection of personal data, informs that the personal data collected through the forms on the Website: https://www.marbellaroyalclinic.com/ are included in the specific automated files of users of the services of MARBELLA ROYAL CLINIC.
The automated collection and processing of personal data are intended to maintain the business relationship and perform information, training, consulting and other activities of MARBELLA ROYAL CLINIC. These data will only be transferred to those entities that are necessary for the sole purpose of fulfilling the above mentioned criteria.
MARBELLA ROYAL CLINIC adopts necessary measures to guarantee the security, integrity and confidentiality of data, following the provisions of Regulation (EU) 2016/679 of the European Parliament and of the Council, of April 27, 2016, regarding the protection of natural persons concerning the processing of personal data and their free movement.
The user may at any time exercise the rights of access, opposition, rectification, cancellation, limitation, and portability recognized in the Regulation (EU). The exercise of these rights can be done by the user himself via email to firstname.lastname@example.org or at the address:
In the case of contract for the goods and services offered through https://www.marbellaroyalclinic.com/ to maintain the contractual relationship, as well as the management, administration, information, provision and improvement of the service.
Sending requested information through the forms provided at https://www.marbellaroyalclinic.com/.
Send newsletters, as well as commercial communications of promotions and/or advertising from https://www.marbellaroyalclinic.com/ and the sector.
We remind you that you can oppose the sending of commercial communications, by any means and at any time, by sending an email to the above address.
The fields of these records are mandatory, making it impossible to carry out the stated purposes if these data are not provided.
How long is the collected personal data kept?
The personal data provided by the user will be kept if the commercial relationship is maintained; or in-case you do not request its deletion and during the period for which legal responsibilities for the services provided may arise.
The processing of your data is carried out with the following legal bases that legitimize it:
1. The request for information and/or the contract for services of MARBELLA ROYAL CLINIC, whose terms and conditions will be made available to you in any case, before any eventual contract.
If you do not provide us with your data or you do so erroneously or incompletely, we will not be able to attend to your request, making it completely impossible to provide you with the requested information or to carry out the contract for services.
The data will not be communicated to any third party outside MARBELLA ROYAL CLINIC, except under legal obligation. Eventually, potential providers or service providers with access to information will have potential access to their data, hired on a commercial basis by MARBELLA ROYAL CLINIC, only after signing a confidentiality contract and ordering treatment. Access will be limited to the data necessary to fulfil the contract for services.
Data collected by users of the services
In cases where the user includes files with personal data on shared hosting servers, MARBELLA ROYAL CLINIC is not responsible for the user's failure to comply with the RGPD.
Data retention Following the LSSI
MARBELLA ROYAL CLINIC informs that, as a provider of data hosting service and according to the provisions of Law 34/2002 of July 11 on Services of the Information Society and Electronic Commerce (LSSI), the clinic retains for a maximum period of 12 months, the essential information to identify the origin of the data stored and the moment in which the provision of the service began. The retention of these data does not affect the secrecy of communications and may only be used in the framework of a criminal investigation or for the safeguarding of public safety, making themselves available to judges and/or courts or the Ministry that so requires. The communication of data to the State Forces and Bodies will be made by following the provisions of the regulations on the protection of personal data.
MARBELLA ROYAL CLINIC is the owner of all copyrights, intellectual and industrial property related to https://www.marbellaroyalclinic.com/ and the services offered therein, as well as the programs necessary for its implementation and related information.
Reproduction, publication and/or non-strictly private use of the contents, total or partial, of the website https://www.marbellaroyalclinic.com/, is not allowed without prior written consent.
The intellectual property of the software
The user must respect the third-party programs made available by MARBELLA ROYAL CLINIC, even if they are free and/or publicly available. MARBELLA ROYAL CLINIC has the necessary exploitation rights and intellectual property of the software.
The user does not acquire any rights or license for the contract for services, on the software necessary for the provision of the service, nor on the technical information for monitoring the service, except for the rights and licenses necessary for the fulfilment of the contract for services and only for the duration of them.
For any action that exceeds the fulfilment of the contract, the user will need written authorization from MARBELLA ROYAL CLINIC, and the user is prohibited from accessing, modifying, viewing the configuration, structure and files of the servers owned by MARBELLA ROYAL CLINIC, failure of this will lead to assuming civil and criminal liability derived from any incident that may occur in servers and security systems as a direct consequence of negligent or malicious action on their part.
The intellectual property of hosted content
The use contrary to the legislation on the intellectual property of the services provided by MARBELLA ROYAL CLINIC and, of:
The use that is contrary to Spanish laws or that infringes the rights of third parties is prohibited.
The publication or transmission of any content that, in the opinion of MARBELLA ROYAL CLINIC, is violent, obscene, abusive, illegal, racial, xenophobic or defamatory.
Cracks, serial numbers of programs or any other content that violates the intellectual property rights of third parties.
The collection and/or use of personal data of other users without their express consent or in contravention of the provisions of Regulation (EU) 2016/679 of the European Parliament and of the Council, of April 27, 2016, regarding the protection of natural persons, concerning the processing of personal data and the free movement of the same. The use of the domain's mail server and email addresses to send mass spam.
The user has full responsibility for the content of its website, the information transmitted and stored, hypertext links, third party claims and legal actions regarding intellectual property, third party rights and protection of minors.
The user is responsible for the laws and regulations in force and the rules that have to do with the operation of the online service, electronic commerce, copyrights, maintenance of public order, as well as universal principles of Internet use.
The user will indemnify MARBELLA ROYAL CLINIC for the expenses generated by the imputation of MARBELLA ROYAL CLINIC in any case, whose responsibility was attributable to the user, including legal defence fees and expenses, even in the case of a non-final judicial decision.
Protection of the information hosted
MARBELLA ROYAL CLINIC makes backup copies of the content hosted on its servers; however, it is not responsible for the loss or accidental deletion of data by users. Likewise, it does not guarantee
the full replacement of the data deleted by users, since the data could have been deleted and/or modified during the time since the last backup.
The services offered, except for the specific backup services, do not include the replacement of the contents kept in the backup copies made by MARBELLA ROYAL CLINIC, when this loss is attributable to the user. In this case, a rate will be determined according to the complexity and volume of the recovery, always with the prior acceptance of the user.
The replacement of deleted data is only included in the price of the service when the loss of content is due to causes attributable to MARBELLA ROYAL CLINIC.
In the application of the LSSI, MARBELLA ROYAL CLINIC will not send advertising or promotional communications by email or other equivalent electronic means of communication that have not previously been requested or expressly authorized by their recipients.
In the case of users with whom there is a prior contractual relationship, MARBELLA ROYAL CLINIC is authorized to send commercial communications regarding products or services of MARBELLA ROYAL CLINIC, which are similar to those initially contracted with the client.
In any case, the user, after proving his identity, may request that no more commercial information be sent to him through the Customer Service channels.